Search Result "PRRT"
Overview of Development and Formulation of 177Lu-DOTA-TATE for PRRT
Journal: Current Radiopharmaceuticals
Volume: 9 Issue: 1 Year: 2016 Page: 8-18
Author(s): Wouter A.P. Breeman,Ho Sze Chan,Rory M.S. de Zanger,Mark K. Konijnenberg,Erik de Blois
Toxicity and Tolerability of 177Lu-DOTA-TATE PRRT with a Modified AdministeredActivity Protocol in NETs of Variable Origin â A Phase 2 RegistryStudy
Journal: Current Radiopharmaceuticals
Volume: 15 Issue: 2 Year: 2022 Page: 123-133
Author(s): Alireza Khatami,Golmehr Sistani,Duncan E. K. Sutherland,Sarah DeBrabandere,Robert H. Reid,David T. Laidley
Peptide Receptor Radionuclide Therapy: Looking Back, Looking Forward
Journal: Current Topics in Medicinal Chemistry
Volume: 20 Issue: 32 Year: 2020 Page: 2959-2969
Author(s): Danny Feijtel,Marion de Jong,Julie Nonnekens
Accurate assessment of whole-body retention for PRRT with 177Lu using paired measurements with external detectors
Journal: Current Radiopharmaceuticals
Volume: 8 Issue: 2 Year: 2015 Page: 129-138
Author(s): Boxue Liu,Erik de Blois,Wouter A.P. Breeman,Mark W. Konijnenberg,Hubert T. Wolterbeek,Peter Bode
Peptide Receptor Radionuclide Therapy for Pancreatic Neuroendocrine Tumours
Journal: Current Radiopharmaceuticals
Volume: 12 Issue: 2 Year: 2019 Page: 126-134
Author(s): Shahad Alsadik,Siraj Yusuf,Adil AL-Nahhas
Peptide-based Radiopharmaceuticals for Targeted Tumor Therapy
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 1 Year: 2014 Page: 139-152
Author(s): C. Dong, Z. Liu, F. Wang
Monitoring Kidney Function in Neuroendocrine Tumor Patients Treated with 90Y-DOTATOC: Associations with Risk Factors
Journal: Current Radiopharmaceuticals
Volume: 8 Issue: 1 Year: 2015 Page: 49-55
Author(s): Anne K. Arveschoug,Stine M. J. Kramer,Peter Iversen,Jorgen Frokiaer,Henning Gronbaek
Current Status and Perspectives in Peptide Receptor Radiation Therapy
Journal: Current Pharmaceutical Design
Volume: 15 Issue: 2 Year: 2009 Page: 2453-2462
Author(s): Catherine Ansquer, Francoise Kraeber-Bodere, Jean Francoise Chatal
Peptide Receptor Radionuclide Therapy with Somatostatin Analogues in Neuroendocrine Tumors
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12 Issue: 5 Year: 2012 Page: 526-542
Author(s): Giampiero Giovacchini,Guillaume Nicolas,Flavio Forrer
Physiopathological Premises to Nuclear Medicine Imaging of Pancreatic Neuroendocrine Tumours
Journal: Current Radiopharmaceuticals
Volume: 12 Issue: 2 Year: 2019 Page: 98-106
Author(s): Vincenzo Cuccurullo,Giuseppe Danilo Di Stasio,Luigi Mansi